Navigation Links
Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
Date:2/12/2008

s we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended September 30, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
2. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
3. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
4. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
5. Webcast Alert: Kaiser Permanente Residency Program Open House
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
8. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
9. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
10. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
11. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... ORLEANS, Dec. 7 Cell Therapeutics, Inc. ... Ruth Pettengell, M.D. of St. George,s Hospital, University ... American Society of Hematology ("ASH") Annual Meeting updated ... 301) clinical trial of pixantrone (the "PIX 301 ... lymphoma ("NHL") patients who have failed 2 ...
(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... oysters harvested from San Antonio Bay ,, SILVER ... and Drug Administration is advising consumers to avoid eating ... after Nov. 16 due to reports of norovirus-associated illnesses ... this area, which is located on the Gulf of ... ,, The FDA, along with the Centers for Disease ...
(Date:12/6/2009)... Cambridge have discovered that the loss of a key segment ... the first study to show that this kind of genetic ... Nature . , The study, led by Dr Sadaf ... from the Wellcome Trust Sanger Institute, looked at 300 children ... genome looking for types of mutation known as copy number ...
Breaking Medicine News(10 mins):Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Recognized Top Performers in UHC Supply Chain 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2
... England franchisees have donated over $7 Million for ... Dunkin, Donuts store owners,in New England Monday ... Jimmy Fund through proceeds generated from the 11th ... Auction. The,event, organized by Dunkin, Donuts Northeast Distribution ...
... The American Red Cross is still working in ... Peru, Aug. 13 When the massive,earthquake struck ... infrastructure destroyed and nearly 140,000 people homeless.,Although the ... is still on the,ground, working with the Peruvian ...
... medspa Blue Water Spa owner Kile Law, will provide expert information to ... Orlando, FL. , ... Raleigh, NC (PRWEB) August 13, 2008 -- Raleigh, ... America. Medical Spa Owner Kile Law, who co-owns Blue Water Spa with ...
... Educational Campaign Offers Tips and Top Technologies to Help Cure Office Headaches ... ... survey conducted by Ponemon Institute, 49 percent of data breaches occur due ... drives. Furthermore, 53 percent of organizations would never know what data ...
... show, , , TUESDAY, Aug. 12 (HealthDay News) -- A host ... long after the conflict ends. , The Aug. 13 issue ... is a special themed issue on violence and human rights, ... mental health issues, such as alcohol misuse and post-traumatic stress ...
... Urged to End Role as It Did with ... For the second time in,recent weeks, international ... to withdraw its sponsorship and promotion of a ... company,s activities appear,to violate national law., Last ...
Other Medicine News:Health News:Dunkin' Donuts Event Raises $800,000 for Cancer Research in One Day 2Health News:One Year Later: Red Cross Helping Peru Earthquake Survivors Rebuild 2Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 2Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 3Health News:Lumension Security Launches Interactive Office Game To Educate IT Professionals On 10 Most Common Security Risks Within The Workplace 2Health News:Lumension Security Launches Interactive Office Game To Educate IT Professionals On 10 Most Common Security Risks Within The Workplace 3Health News:Drinking Problems Greater Among Returning Combat Veterans 2Health News:Drinking Problems Greater Among Returning Combat Veterans 3Health News:Philip Morris International Caught in Philippines in Another Concert Sponsorship 2Health News:Philip Morris International Caught in Philippines in Another Concert Sponsorship 3
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, announced today the presentation of new data from ... recombinant Protective Antigen (rPA) based anthrax vaccine is structurally ... up to and including 55 degrees C. The ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Web Based Psychotherapy Can Work 55000 1Web Based Psychotherapy Can Work 55000 2Web Based Psychotherapy Can Work 55000 3Learning how to cope with burn injuries 54996 1Learning how to cope with burn injuries 54996 2Learning how to cope with burn injuries 54996 3Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 1Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 2
... ANTIPOLIS, France, Oct. 2 NicOx S.A.,(Eurolist: ... clinical and,preclinical results from its collaboration with ... of Dermatology, in Buenos Aires, Argentina.,These included ... prototype compound, showing,the potential for improved safety ...
... Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) today announced that ... overview of the Company,s cancer,pipeline at the upcoming William ... City. Dr. Henderson,s presentation will take place,on Wednesday, October ... will be webcast live and will be,accessible from the ...
Other Medicine Technology:NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 2NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 3Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2